Virax Biolabs Group Limited Ordinary Shares (VRAX) is a publicly traded Healthcare sector company. As of July 9, 2026, VRAX trades at $9.19 with a market cap of $2.42M and a P/E ratio of 0.00. VRAX moved +189.62% today. Year to date, VRAX is -63.22%; over the trailing twelve months it is -85.32%. Its 52-week range spans $2.50 to $80.00. Rallies surfaces VRAX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for VRAX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $9.19 |
| Market Cap | $2.42M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $80.00 |
| 52-Week Low | $2.50 |
| Volume | 58.94M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
VRAX analyst coverage data. Average price target: $0.00.